Disclosures for "Switching from galcanezumab to fremanezumab in migraine patients: a retrospective analysis")
-
Prof. Takizawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Otsuka. Prof. Takizawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Prof. Takizawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Prof. Takizawa has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Otsuka. Prof. Takizawa has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eli Lilly. Prof. Takizawa has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Daiichi Sankyo. Prof. Takizawa has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amgen. Prof. Takizawa has received research support from Eli Lilly Japan. Prof. Takizawa has received research support from Tsumura. Prof. Takizawa has received research support from JSPS KAKENHI.
-
Mr. Ohtani has nothing to disclose.
-
Dr. Watanabe has nothing to disclose.
-
Ms. Ihara has nothing to disclose.
-
Dr. Takahashi has nothing to disclose.
-
Mr. Miyazaki has nothing to disclose.
-
Dr. Takemura has nothing to disclose.
-
Prof. Hori has nothing to disclose.
-
Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mitsubishi-Tanabe. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chugai. Prof. Nakahara has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Prof. Nakahara has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Mitsubishi-Tanabe. Prof. Nakahara has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Takeda. Prof. Nakahara has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. Prof. Nakahara has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Prof. Nakahara has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Daiichi-Sankyo. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teiijin. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Asahi Kasei. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for The Japanese Society for Internal Medicine. Prof. Nakahara has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Kagakuhyoronsha. The institution of Prof. Nakahara has received research support from Biogen. The institution of Prof. Nakahara has received research support from Keio University. The institution of Prof. Nakahara has received research support from Otsuka. The institution of Prof. Nakahara has received research support from Kyowa-Kirin. The institution of Prof. Nakahara has received research support from Chugai. The institution of Prof. Nakahara has received research support from Shionogi. The institution of Prof. Nakahara has received research support from Sumitomo-Dainippon. The institution of Prof. Nakahara has received research support from Eisai. The institution of Prof. Nakahara has received research support from Abbvie. The institution of Prof. Nakahara has received research support from JB. The institution of Prof. Nakahara has received research support from Behringer-Ingelheim. The institution of Prof. Nakahara has received research support from MSD. The institution of Prof. Nakahara has received research support from Tsumura. The institution of Prof. Nakahara has received research support from EA Pharma. The institution of Prof. Nakahara has received research support from Daiichi-Sankyo.